These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36209980)

  • 21. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
    Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
    Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Luc J; Vandermander J; Michel G
    Skin Pharmacol; 1991; 4(2):89-94. PubMed ID: 1831626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciclopirox nail lacquer solution 8% in the 21st century.
    Gupta AK; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S96-102. PubMed ID: 11051138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films.
    Täuber A; Müller-Goymann CC
    Int J Pharm; 2015 Jul; 489(1-2):73-82. PubMed ID: 25895717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic approach to the formulation of anti-onychomycotic nail patches.
    Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
    Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.
    Cutrín Gómez E; Anguiano Igea S; Delgado-Charro MB; Gómez Amoza JL; Otero Espinar FJ
    Eur J Pharm Biopharm; 2018 Jul; 128():48-56. PubMed ID: 29673870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
    Täuber A; Müller-Goymann CC
    Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
    Gupta AK; Polla Ravi S; Choi SY; Konda A; Cooper EA
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):243-255. PubMed ID: 36196052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine.
    Nogueiras-Nieto L; Begoña Delgado-Charro M; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2013 Apr; 83(3):370-7. PubMed ID: 23201053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
    Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
    Pal P; Thakur RS; Ray S; Mazumder B
    Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciclopirox delivery into the human nail plate.
    Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
    J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
    Hossin B; Rizi K; Murdan S
    Eur J Pharm Biopharm; 2016 May; 102():32-40. PubMed ID: 26924329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
    Abd-Elsalam WH; Abouelatta SM
    AAPS PharmSciTech; 2023 Jul; 24(6):150. PubMed ID: 37421509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis.
    Yu B; Zhou G; Wang B; Ben Y; Yan H; Shao Y; Wang B
    Chin Med Sci J; 1991 Sep; 6(3):166-8. PubMed ID: 1838936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.
    Seebacher C; Nietsch KH; Ulbricht HM
    Cutis; 2001 Aug; 68(2 Suppl):17-22. PubMed ID: 11665724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.